AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · Real-Time Price · USD
5.25
+2.40 (84.21%)
At close: Mar 9, 2026, 4:00 PM EDT
5.03
-0.22 (-4.19%)
After-hours: Mar 9, 2026, 6:46 PM EDT
AN2 Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 144 | 41 | 609 | 185 | - | - | |
| Market Cap Growth | 326.09% | -93.23% | 229.57% | - | - | - | |
| Enterprise Value | 83 | -52 | 486 | 81 | - | - | |
| Last Close Price | 5.30 | 1.38 | 20.49 | 9.53 | - | - | |
| PB Ratio | 2.40 | 0.50 | 4.89 | 1.94 | - | - | |
| P/TBV Ratio | 2.41 | 0.50 | 4.89 | 1.94 | - | - | |
| Debt / Equity Ratio | - | - | - | 0.00 | - | - | |
| Net Debt / Equity Ratio | -1.03 | -1.02 | -0.86 | -1.01 | -0.95 | -1.48 | |
| Quick Ratio | 9.12 | 8.20 | 7.74 | 13.37 | 17.25 | 2.79 | |
| Current Ratio | 9.33 | 8.43 | 7.87 | 13.72 | 17.70 | 2.90 | |
| Return on Equity (ROE) | -45.91% | -49.69% | -58.83% | -52.08% | -66.64% | -359.68% | |
| Return on Assets (ROA) | -28.35% | -29.54% | -36.07% | -31.47% | -38.77% | -91.66% | |
| Return on Capital Employed (ROCE) | -61.90% | -66.70% | -55.80% | -44.30% | -34.80% | -262.50% | |
| Earnings Yield | -23.40% | -124.47% | -10.62% | -22.15% | - | - | |
| Buyback Yield / Dilution | -0.97% | -26.39% | -53.85% | -481.46% | -2.71% | -0.61% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.